Winklevoss Asset Services has filed with the SEC to launch a Nasdaq-listed spot Zcash ETF under the ticker WINK, which would hold Zcash (ZEC) tokens directly with Gemini Trust as custodian. The ETF would allow authorized participants to create and redeem shares using cash, separating share transactions from direct cryptocurrency handling. This move follows Grayscale's existing Zcash ETF, which recently saw significant withdrawals. The filing comes ahead of a key Oct. 20 decision on Zcash's NU7 mainnet upgrade, which could impact the network's performance and ZEC issuance. The proposal awaits regulatory approval before trading can begin.
The Winklevoss spot Zcash ETF filing provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 07, 2026 01:12 WIB: out of 50 priced cryptocurrencies, 24 rose and 25 fell. Cardano (ADA) rose 2.93% to Rp4.877 with a typical hold time of 126 days, while Curve DAO Token (CRV) fell 2.64% to Rp6.488 and Algorand (ALGO) dropped 2.55% to Rp2.216 with a typical hold time of 129 days.
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...
An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...
An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...
